Ashley Mathai
Psychiatric/Mental Health · Staten Island, NYNPI 1306330295
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $61.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$790
- E.r. Squibb & Sons, L.L.C.$629
- Axsome Therapeutics, Inc.$363
- plus $1K from 11 others
What the payments were for
- Food & beverage$7,907100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 20 | $1,667 |
| AbbVie | 22 | $1,575 |
| Otsuka America Pharmaceutical, Inc. | 25 | $1,403 |
| Teva Pharmaceuticals USA, Inc. | 8 | $790 |
| E.r. Squibb & Sons, L.L.C. | 5 | $629 |
| Axsome Therapeutics, Inc. | 3 | $363 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $262 |
| Lundbeck LLC | 11 | $260 |
| Pfizer | 2 | $239 |
| Johnson & Johnson | 8 | $179 |
| Alkermes, Inc. | 9 | $172 |
| Gilead | 2 | $130 |
| GSK | 1 | $124 |
| Almatica Pharma LLC | 2 | $53 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$1,206
- VRAYLAR$1,200
- COBENFY$629
- REXULTI$499
- Austedo XR$493
- ABILIFY MAINTENA$489
- Auvelity$246
- UZEDY$246
- NURTEC ODT$239
- CAPLYTA$127
- TRELEGY ELLIPTA$124
- ABILIFY ASIMTUFII$121
- Symbravo$117
How this compares
$7,907 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 38 | $1,815 |
| Divalproex Sodium | 35 | $585 |
| Haloperidol | 17 | $545 |
| Olanzapine OdtOlanzapine | 12 | $439 |
| Benztropine Mesylate | 18 | $137 |
| Aripiprazole | 13 | $107 |
| Risperidone | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Staten Island
- Kevin SiewersStaten Island$155K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
- Vera ImperialeAlbany$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.